Advertisement

Index by author

November 01, 1990; Volume 38,Issue 5

A

  1. Adams, M E

    1. Inhibition of neuronal Ca2+ channel currents by the funnel web spider toxin omega-Aga-IA.
      R H Scott, A C Dolphin, V P Bindokas and M E Adams
      Molecular Pharmacology November 1990, 38 (5) 711-718;

  2. Adham, N

    1. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;
    2. Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;

  3. Anderson, W R

    1. Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: possible role in alcoholic cirrhosis.
      J R Trudell, C M Ardies and W R Anderson
      Molecular Pharmacology November 1990, 38 (5) 587-593;

  4. Ardies, C M

    1. Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: possible role in alcoholic cirrhosis.
      J R Trudell, C M Ardies and W R Anderson
      Molecular Pharmacology November 1990, 38 (5) 587-593;

  5. Arnaudeau, S

    1. Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;

B

  1. Bindokas, V P

    1. Inhibition of neuronal Ca2+ channel currents by the funnel web spider toxin omega-Aga-IA.
      R H Scott, A C Dolphin, V P Bindokas and M E Adams
      Molecular Pharmacology November 1990, 38 (5) 711-718;

  2. Branchek, T

    1. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;

  3. Branchek, T A

    1. Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;

C

  1. Candell, L M

    1. Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
      L M Candell, S H Yun, L L Tran and F J Ehlert
      Molecular Pharmacology November 1990, 38 (5) 689-697;

  2. Caron, M G

    1. Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;

  3. Clark, M A

    1. Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;

  4. Collins, S

    1. Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;

  5. Costa, E

    1. Transcriptional program coordination by N-methyl-D-aspartate-sensitive glutamate receptor stimulation in primary cultures of cerebellar neurons.
      A M Szekely, E Costa and D R Grayson
      Molecular Pharmacology November 1990, 38 (5) 624-633;

  6. Cribb, A E

    1. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.
      A E Cribb, M Miller, A Tesoro and S P Spielberg
      Molecular Pharmacology November 1990, 38 (5) 744-751;

D

  1. Dacquet, C

    1. Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;

  2. Dolphin, A C

    1. Inhibition of neuronal Ca2+ channel currents by the funnel web spider toxin omega-Aga-IA.
      R H Scott, A C Dolphin, V P Bindokas and M E Adams
      Molecular Pharmacology November 1990, 38 (5) 711-718;

E

  1. Egan, R W

    1. Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;

  2. Ehlert, F J

    1. Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
      L M Candell, S H Yun, L L Tran and F J Ehlert
      Molecular Pharmacology November 1990, 38 (5) 689-697;

F

  1. Fredholm, B B

    1. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
      P Gerwins, C Nordstedt and B B Fredholm
      Molecular Pharmacology November 1990, 38 (5) 660-666;

G

  1. Gerwins, P

    1. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
      P Gerwins, C Nordstedt and B B Fredholm
      Molecular Pharmacology November 1990, 38 (5) 660-666;

  2. Grayson, D R

    1. Transcriptional program coordination by N-methyl-D-aspartate-sensitive glutamate receptor stimulation in primary cultures of cerebellar neurons.
      A M Szekely, E Costa and D R Grayson
      Molecular Pharmacology November 1990, 38 (5) 624-633;

  3. Guenthner, T M

    1. Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes.
      C W Wheeler, S S Park and T M Guenthner
      Molecular Pharmacology November 1990, 38 (5) 634-643;

H

  1. Hartig, P R

    1. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;
    2. Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;

  2. Hashimoto, K

    1. Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
      E Suzuki, G Tsujimoto, K Tamura and K Hashimoto
      Molecular Pharmacology November 1990, 38 (5) 725-736;

  3. Higuchi, H

    1. Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
      H Higuchi, A Iwasa, H Yoshida and N Miki
      Molecular Pharmacology November 1990, 38 (5) 614-623;

  4. Hoffman, B J

    1. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
      M Teitler, S Leonhardt, E L Weisberg and B J Hoffman
      Molecular Pharmacology November 1990, 38 (5) 594-598;

I

  1. Iwasa, A

    1. Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
      H Higuchi, A Iwasa, H Yoshida and N Miki
      Molecular Pharmacology November 1990, 38 (5) 614-623;

J

  1. Jmari, K

    1. Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;

  2. Johnson, K M

    1. Competitive inhibition of magnesium-induced [3H]N-(1-[thienyl] cyclohexyl)piperidine binding by arcaine: evidence for a shared spermidine-magnesium binding site.
      A I Sacaan and K M Johnson
      Molecular Pharmacology November 1990, 38 (5) 705-710;

  3. Jordan, V C

    1. Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
      C S Murphy, S M Langan-Fahey, R McCague and V C Jordan
      Molecular Pharmacology November 1990, 38 (5) 737-743;

K

  1. Kamataki, T

    1. Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs.
      T Uchida, M Komori, M Kitada and T Kamataki
      Molecular Pharmacology November 1990, 38 (5) 644-651;

  2. Kao, H T

    1. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;

  3. Kitada, M

    1. Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs.
      T Uchida, M Komori, M Kitada and T Kamataki
      Molecular Pharmacology November 1990, 38 (5) 644-651;

  4. Komori, M

    1. Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs.
      T Uchida, M Komori, M Kitada and T Kamataki
      Molecular Pharmacology November 1990, 38 (5) 644-651;

L

  1. Langan-Fahey, S M

    1. Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
      C S Murphy, S M Langan-Fahey, R McCague and V C Jordan
      Molecular Pharmacology November 1990, 38 (5) 737-743;

  2. Lefkowitz, R J

    1. Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;

  3. Leonhardt, S

    1. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
      M Teitler, S Leonhardt, E L Weisberg and B J Hoffman
      Molecular Pharmacology November 1990, 38 (5) 594-598;

  4. Lichtblau, H

    1. Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;

  5. Lomasney, J W

    1. Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;

  6. Lorenz, W

    1. Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;

M

  1. Macchi, M

    1. [3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine) and [3H] ketanserin label two affinity states of the cloned human 5-hydroxytryptamine2 receptor.
      T Branchek, N Adham, M Macchi, H T Kao and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 604-609;
    2. Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;

  2. Mante, S

    1. Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
      S Mante and K P Minneman
      Molecular Pharmacology November 1990, 38 (5) 652-659;

  3. Martin, C

    1. Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;

  4. McCague, R

    1. Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
      C S Murphy, S M Langan-Fahey, R McCague and V C Jordan
      Molecular Pharmacology November 1990, 38 (5) 737-743;

  5. Mehta, A K

    1. gamma-Aminobutyric acidA receptor desensitization in mice spinal cord cultured neurons: lack of involvement of protein kinases A and C.
      M K Ticku and A K Mehta
      Molecular Pharmacology November 1990, 38 (5) 719-724;

  6. Miki, N

    1. Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
      H Higuchi, A Iwasa, H Yoshida and N Miki
      Molecular Pharmacology November 1990, 38 (5) 614-623;

  7. Miller, M

    1. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.
      A E Cribb, M Miller, A Tesoro and S P Spielberg
      Molecular Pharmacology November 1990, 38 (5) 744-751;

  8. Minneman, K P

    1. Is adenosine involved in inhibition of forskolin-stimulated cyclic AMP accumulation by caffeine in rat brain?
      S Mante and K P Minneman
      Molecular Pharmacology November 1990, 38 (5) 652-659;

  9. Mironneau, C

    1. Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;

  10. Mironneau, J

    1. Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;

  11. Murphy, C S

    1. Structure-function relationships of hydroxylated metabolites of tamoxifen that control the proliferation of estrogen-responsive T47D breast cancer cells in vitro.
      C S Murphy, S M Langan-Fahey, R McCague and V C Jordan
      Molecular Pharmacology November 1990, 38 (5) 737-743;

  12. Musílková, J

    1. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;

N

  1. Nedoma, J

    1. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;

  2. Nordstedt, C

    1. Characterization of adenosine A1 receptors in intact DDT1 MF-2 smooth muscle cells.
      P Gerwins, C Nordstedt and B B Fredholm
      Molecular Pharmacology November 1990, 38 (5) 660-666;

P

  1. Park, S S

    1. Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes.
      C W Wheeler, S S Park and T M Guenthner
      Molecular Pharmacology November 1990, 38 (5) 634-643;

  2. Proska, J

    1. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;

  3. Prozialeck, W C

    1. Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
      S P Zhang, W C Prozialeck and B Weiss
      Molecular Pharmacology November 1990, 38 (5) 698-704;

R

  1. Rakotoarisoa, L

    1. Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;

  2. Regan, J W

    1. Expression of three alpha 2-adrenergic receptor subtypes in rat tissues: implications for alpha 2 receptor classification.
      W Lorenz, J W Lomasney, S Collins, J W Regan, M G Caron and R J Lefkowitz
      Molecular Pharmacology November 1990, 38 (5) 599-603;

S

  1. Sacaan, A I

    1. Competitive inhibition of magnesium-induced [3H]N-(1-[thienyl] cyclohexyl)piperidine binding by arcaine: evidence for a shared spermidine-magnesium binding site.
      A I Sacaan and K M Johnson
      Molecular Pharmacology November 1990, 38 (5) 705-710;

  2. Sayet, I

    1. Identification and properties of voltage-sensitive sodium channels in smooth muscle cells from pregnant rat myometrium.
      C Martin, S Arnaudeau, K Jmari, L Rakotoarisoa, I Sayet, C Dacquet, C Mironneau and J Mironneau
      Molecular Pharmacology November 1990, 38 (5) 667-673;

  3. Scott, R H

    1. Inhibition of neuronal Ca2+ channel currents by the funnel web spider toxin omega-Aga-IA.
      R H Scott, A C Dolphin, V P Bindokas and M E Adams
      Molecular Pharmacology November 1990, 38 (5) 711-718;

  4. Shelkovnikov, S

    1. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;

  5. Shih, N Y

    1. Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;

  6. Siegel, M I

    1. Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;

  7. Spielberg, S P

    1. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.
      A E Cribb, M Miller, A Tesoro and S P Spielberg
      Molecular Pharmacology November 1990, 38 (5) 744-751;

  8. Suzuki, E

    1. Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
      E Suzuki, G Tsujimoto, K Tamura and K Hashimoto
      Molecular Pharmacology November 1990, 38 (5) 725-736;

  9. Szekely, A M

    1. Transcriptional program coordination by N-methyl-D-aspartate-sensitive glutamate receptor stimulation in primary cultures of cerebellar neurons.
      A M Szekely, E Costa and D R Grayson
      Molecular Pharmacology November 1990, 38 (5) 624-633;

T

  1. Tamura, K

    1. Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
      E Suzuki, G Tsujimoto, K Tamura and K Hashimoto
      Molecular Pharmacology November 1990, 38 (5) 725-736;

  2. Teitler, M

    1. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
      M Teitler, S Leonhardt, E L Weisberg and B J Hoffman
      Molecular Pharmacology November 1990, 38 (5) 594-598;

  3. Tesoro, A

    1. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs.
      A E Cribb, M Miller, A Tesoro and S P Spielberg
      Molecular Pharmacology November 1990, 38 (5) 744-751;

  4. Ticku, M K

    1. gamma-Aminobutyric acidA receptor desensitization in mice spinal cord cultured neurons: lack of involvement of protein kinases A and C.
      M K Ticku and A K Mehta
      Molecular Pharmacology November 1990, 38 (5) 719-724;

  5. Tran, L L

    1. Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
      L M Candell, S H Yun, L L Tran and F J Ehlert
      Molecular Pharmacology November 1990, 38 (5) 689-697;

  6. Trudell, J R

    1. Cross-reactivity of antibodies raised against acetaldehyde adducts of protein with acetaldehyde adducts of phosphatidyl-ethanolamine: possible role in alcoholic cirrhosis.
      J R Trudell, C M Ardies and W R Anderson
      Molecular Pharmacology November 1990, 38 (5) 587-593;

  7. Tsujimoto, G

    1. Two pharmacologically distinct alpha 1-adrenoceptor subtypes in the contraction of rabbit aorta: each subtype couples with a different Ca2+ signalling mechanism and plays a different physiological role.
      E Suzuki, G Tsujimoto, K Tamura and K Hashimoto
      Molecular Pharmacology November 1990, 38 (5) 725-736;

  8. Tucek, S

    1. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;

U

  1. Uchida, T

    1. Isolation of cDNAs coding for three different forms of liver microsomal cytochrome P-450 from polychlorinated biphenyl-treated beagle dogs.
      T Uchida, M Komori, M Kitada and T Kamataki
      Molecular Pharmacology November 1990, 38 (5) 644-651;

V

  1. Vorlícek, J

    1. Positive cooperativity in the binding of alcuronium and N-methylscopolamine to muscarinic acetylcholine receptors.
      S Tucek, J Musílková, J Nedoma, J Proska, S Shelkovnikov and J Vorlícek
      Molecular Pharmacology November 1990, 38 (5) 674-680;

W

  1. Weinshank, R L

    1. Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;

  2. Weisberg, E L

    1. 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]ketanserin labeling of 5-hydroxytryptamine2 (5HT2) receptors in mammalian cells transfected with a rat 5HT2 cDNA: evidence for multiple states and not multiple 5HT2 receptor subtypes.
      M Teitler, S Leonhardt, E L Weisberg and B J Hoffman
      Molecular Pharmacology November 1990, 38 (5) 594-598;

  3. Weiss, B

    1. Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
      S P Zhang, W C Prozialeck and B Weiss
      Molecular Pharmacology November 1990, 38 (5) 698-704;

  4. West, R E

    1. Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;

  5. Wheeler, C W

    1. Immunochemical analysis of a cytochrome P-450IA1 homologue in human lung microsomes.
      C W Wheeler, S S Park and T M Guenthner
      Molecular Pharmacology November 1990, 38 (5) 634-643;

Y

  1. Yoshida, H

    1. Long lasting increase in neuropeptide Y gene expression in rat adrenal gland with reserpine treatment: positive regulation of transsynaptic activation and membrane depolarization.
      H Higuchi, A Iwasa, H Yoshida and N Miki
      Molecular Pharmacology November 1990, 38 (5) 614-623;

  2. Yun, S H

    1. Differential coupling of subtypes of the muscarinic receptor to adenylate cyclase and phosphoinositide hydrolysis in the longitudinal muscle of the rat ileum.
      L M Candell, S H Yun, L L Tran and F J Ehlert
      Molecular Pharmacology November 1990, 38 (5) 689-697;

Z

  1. Zgombick, J M

    1. Cloning, expression, and pharmacological characterization of a human alpha 2B-adrenergic receptor.
      R L Weinshank, J M Zgombick, M Macchi, N Adham, H Lichtblau, T A Branchek and P R Hartig
      Molecular Pharmacology November 1990, 38 (5) 681-688;

  2. Zhang, S P

    1. Differential inhibition of calcium-dependent and calmodulin-dependent enzymes by drug-calmodulin adducts.
      S P Zhang, W C Prozialeck and B Weiss
      Molecular Pharmacology November 1990, 38 (5) 698-704;

  3. Zweig, A

    1. Identification of two H3-histamine receptor subtypes.
      R E West, A Zweig, N Y Shih, M I Siegel, R W Egan and M A Clark
      Molecular Pharmacology November 1990, 38 (5) 610-613;
Back to top

In this issue